MabVax Therapeutics Holdings, Inc.
(Other OTC/NBB : MBVX)

( )
MBVX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson -0.66%158.510.7%$1180.25m
MRKMerck & Co., Inc. 0.35%76.720.7%$1003.69m
PFEPfizer Inc. 0.08%37.200.9%$1001.79m
ABBVAbbVie, Inc. -1.01%107.111.9%$822.90m
BMYBristol-Myers Squibb Co. -0.38%63.371.0%$730.48m
LLYEli Lilly & Co. 0.38%183.201.1%$689.46m
AZNAstraZeneca Plc 1.24%49.801.2%$437.40m
GSKGlaxoSmithKline Plc 0.28%36.140.2%$182.12m
RPRXRoyalty Pharma Plc 0.00%41.430.2%$160.14m
NVSNovartis AG -0.04%86.590.2%$151.30m
VTRSViatris, Inc. 0.93%13.090.0%$128.95m
RGENRepligen Corp. 0.00%212.866.8%$92.84m
CVACCureVac NV 4.03%99.500.0%$77.60m
ATNF180 Life Sciences Corp. -2.32%10.540.0%$62.81m
SNYSanofi 0.58%50.450.2%$60.73m

Company Profile

MabVax Therapeutics Holdings, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing innovative vaccine and monoclonal antibody-based therapeutics for the diagnosis and treatment of cancer. The company was founded on July 8, 2014 and is headquartered in San Diego, CA.